Roselyn Torres Riera
Nurse Practitioner · Saint Cloud, FLNPI 1528591708
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 96 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 13.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,837, more than ten times the $20 reported in 2021.
Across 96 payments — averaging $23.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$303
- Sanofi-aventis U.S. LLC$205
- Bayer$193
- Amgen$172
- Madrigal Pharmaceuticals$118
- Boehringer Ingelheim$99
- plus $1K from 20 others
What the payments were for
- Food & beverage$2,209100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 15 | $303 |
| Sanofi-aventis U.S. LLC | 8 | $205 |
| Bayer | 8 | $193 |
| Amgen | 8 | $172 |
| Madrigal Pharmaceuticals | 4 | $118 |
| Boehringer Ingelheim | 5 | $99 |
| Medtronic | 3 | $99 |
| Ascendis Pharma Endocrinology Inc | 4 | $89 |
| Radius Health, Inc. | 3 | $88 |
| Tandem Diabetes Care, Inc. | 4 | $82 |
| Lilly USA, LLC | 5 | $82 |
| Amneal Pharmaceuticals LLC | 4 | $78 |
| Recordati_rare_diseases_inc. | 4 | $77 |
| Cequr Corporation | 1 | $71 |
| Xeris Pharmaceuticals, Inc. | 3 | $62 |
| AbbVie | 3 | $60 |
| Sequel Med Tech, LLC | 2 | $52 |
| Antares Pharma, Inc. | 2 | $43 |
| Abbott | 2 | $40 |
| Insulet Corporation | 1 | $34 |
| Esperion Therapeutics, Inc. | 2 | $33 |
| Neurocrine Biosciences, Inc. | 1 | $30 |
| Corcept Therapeutics | 1 | $27 |
| Dexcom, Inc. | 1 | $25 |
| Amphastar Pharmaceuticals, Inc. | 1 | $25 |
| Novartis | 1 | $24 |
How this compares
$2,209 in reported general payments places this provider in the 80th percentile of 8,290 nurse practitioner providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine Hcl | 108 | $6,218 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 28 | $3,452 |
| Doxepin Hcl | 12 | $273 |
| Clonazepam | 48 | $270 |
| Amitriptyline Hcl | 14 | $161 |
| Sertraline Hcl | 14 | $139 |
| Tizanidine Hcl | 15 | $84 |
| Simvastatin | 11 | $74 |
| Gabapentin | 15 | $73 |
| Lisinopril | 15 | $41 |
| Amlodipine Besylate | 17 | $41 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Saint Cloud
- Jolanta BaginskiClearwater$494K
- Adissa PerezWinter Park$370K
- April WessonTampa$342K
- Margarita FernandezMiami$311K
- Stephanie SimmermanNaples$283K
- Claudette WalkerPonte Vedra Beach$271K
- Lisa NodzonTampa$246K
- Ashima BahlTampa$226K
- Maya BloombergMiami$202K
- Jennifer PuleoTampa$171K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.